Month: <span>November 2023</span>

Home / 2023 / November
Bacteria Tag Team Tumors with T Cells
Post

Bacteria Tag Team Tumors with T Cells

OCTOBER 31ST, 2023   CONN HASTINGS A team at Columbia University School of Engineering and Applied Science has developed a technique to enhance chimeric antigen receptor (CAR) T cell therapy in solid tumors. The technique involves engineering E. coli bacteria, that naturally tend to accumulate in the immune privileged core of solid tumors. The bacteria have...

Eko’s Newest CORE 500 Stethoscope: A Review
Post

Eko’s Newest CORE 500 Stethoscope: A Review

 ALICE FERNG Arriving in two boxes reminiscent of Apple product packaging – one for the chest piece (the part that contacts the body), and another for the detachable earpiece (tubes + ear tips) – the CORE 500 is clearly an upgrade from the Eko DUOstethoscope. Similar to its predecessor, the CORE 500 can be used...

Urine biomarkers can outperform serum biomarkers in certain diseases
Post

Urine biomarkers can outperform serum biomarkers in certain diseases

Peer-Reviewed Publication KEAI COMMUNICATIONS CO., LTD. URINE BIOMARKERS CAN OUTPERFORM SERUM BIOMARKERS IN CERTAIN DISEASES CREDIT: XUE C, ET AL. In recent decades, the emphasis of biomarker research has centered around blood-based markers. However, blood biomarkers alone cannot capture the full spectrum of clinically relevant indicators. Consequently, urine has emerged as a valuable and complementary...

RCSI study shows survival benefit of augmentation therapy for people with the genetic lung condition AATD
Post

RCSI study shows survival benefit of augmentation therapy for people with the genetic lung condition AATD

Peer-Reviewed Publication RCSI PROFESSOR GERRY MCELVANEY, PROFESSOR OF MEDICINE, RCSI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES AND SENIOR CO-AUTHOR OF A NEW STUDY, PUBLISHED IN THE AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, THAT HAS SHOWN THE SURVIVAL BENEFIT OF AUGMENTATION THERAPY FOR PEOPLE WITH THE GENETIC LUNG CONDITION AATD. CREDIT: RAY LOHAN/ RCSI...

Risk of serious infection even in low-active IBD
Post

Risk of serious infection even in low-active IBD

Peer-Reviewed Publication UNIVERSITY OF GOTHENBURG KARL MÅRILD, SAHLGRENSKA ACADEMY AT THE UNIVERSITY OF GOTHEBURG. CREDIT: PHOTO: REGION VÄSTRA GÖTALAND Inflammatory bowel disease (IBD) is an independent risk factor for serious infection, even at very low levels of gastrointestinal inflammation. This has been shown by a study at the University of Gothenburg. IBD is an umbrella...

Post

American Cancer Society updates lung cancer screening guideline: Nearly five million US adults who smoke and formerly smoked now recommended for testing

Peer-Reviewed Publication AMERICAN CANCER SOCIETY LUNG CANCER SCREENING GUIDELINE UPDATE CREDIT: AMERICAN CANCER SOCIETY ATLANTA, November 1, 2023 — Today, the American Cancer Society (ACS) released an update of its lung cancer screening guideline to help reduce the number of people dying from the disease due to smoking history. The new guideline recommends yearly screening...

Post

High metabolism is an early sign of Alzheimer’s disease, finds study

by Karolinska Institutet Credit: CC0 Public Domain An early phase in the process of developing Alzheimer’s disease is a metabolic increase in a part of the brain called the hippocampus, report researchers from Karolinska Institutet in a study published in Molecular Psychiatry. The discovery opens up for new potential methods of early intervention. Alzheimer’s disease is...

New cancer drug shows promise targeting genetic weakness in tumors
Post

New cancer drug shows promise targeting genetic weakness in tumors

by Virginia Tech Credit: Pixabay/CC0 Public Domain Imagine the body’s cells are well-behaved students in the classroom. The “teachers” are tumor suppressor genes, and they make sure cells follow the rules. But when tumor suppressor genes are away, cells may go astray. With cells, this is a serious matter. Unregulated behavior can lead to uncontrolled growth,...

Post

Study finds JAK inhibitors, common treatment for arthritis, are effective

by Oxford University Press Credit: Unsplash/CC0 Public Domain According to a new paper in Rheumatology, published by Oxford University Press, JAK inhibitors, which doctors have used to treat patients with arthritis despite concerns about the effectiveness of such drugs, actually do work quite well. In a multicenter, retrospective study Japanese researchers found that the drugs resulted...